UHS vs. GMAB
UHS (Universal Health Services, Inc.) and GMAB (Genmab A/S) are both stocks. Both are in the Healthcare sector — UHS in Medical Care Facilities, GMAB in Biotechnology. Over the past 10 years, UHS returned 1.37%/yr vs 4.28%/yr for GMAB. At a 0.14 correlation, their price movements are largely independent.
Performance
UHS vs. GMAB - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, UHS achieves a -32.68% return, which is significantly lower than GMAB's -18.57% return. Over the past 10 years, UHS has underperformed GMAB with an annualized return of 1.37%, while GMAB has yielded a comparatively higher 4.28% annualized return.
UHS
- 1D
- 0.25%
- 1M
- -13.06%
- YTD
- -32.68%
- 6M
- -34.07%
- 1Y
- -14.04%
- 3Y*
- 1.73%
- 5Y*
- -1.29%
- 10Y*
- 1.37%
GMAB
- 1D
- -0.63%
- 1M
- -5.50%
- YTD
- -18.57%
- 6M
- -19.90%
- 1Y
- 9.90%
- 3Y*
- -13.28%
- 5Y*
- -10.53%
- 10Y*
- 4.28%
UHS vs. GMAB - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
UHS Universal Health Services, Inc. | -32.68% | 22.02% | 18.19% | 8.83% | 9.37% | -5.16% | -4.00% | 23.62% | 3.16% | 6.93% |
GMAB Genmab A/S | -18.57% | 47.58% | -34.45% | -24.87% | 7.13% | -2.71% | 82.09% | 35.54% | -0.61% | -0.04% |
Correlation
The correlation between UHS and GMAB is 0.14, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.14 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.19 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.21 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.17 |
Correlation (All Time) Calculated using the full available price history since Jun 1, 2009 | 0.14 |
Fundamentals
UHS:
$31.29
GMAB:
$4.10
UHS:
4.68
GMAB:
6.12
UHS:
0.20
GMAB:
0.41
UHS:
0.40
GMAB:
1.81
UHS:
$17.76B
GMAB:
$8.84B
UHS:
$12.01B
GMAB:
$8.27B
UHS:
$2.79B
GMAB:
$3.81B
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
UHS vs. GMAB — Risk / Return Rank
UHS
GMAB
UHS vs. GMAB - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Universal Health Services, Inc. (UHS) and Genmab A/S (GMAB). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| UHS | GMAB | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -0.74 | ||
| Sortino ratioReturn per unit of downside risk | -1.07 | ||
| Omega ratioGain probability vs. loss probability | 0.93 | 1.07 | -0.14 |
| Calmar ratioReturn relative to maximum drawdown | -0.37 | 0.27 | -0.64 |
| Martin ratioReturn relative to average drawdown | -0.89 | 0.58 | -1.47 |
Loading charts...
Drawdowns
UHS vs. GMAB - Drawdown Comparison
The maximum UHS drawdown since its inception was -60.27%, smaller than the maximum GMAB drawdown of -84.20%. Use the drawdown chart below to compare losses from any high point for UHS and GMAB.
Loading charts...
Drawdown Indicators
| UHS | GMAB | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -60.27% | -84.20% | +23.93% |
Max Drawdown (1Y)Largest decline over 1 year | -41.52% | -32.51% | -9.01% |
Max Drawdown (3Y)Largest decline over 3 years | -41.52% | -57.44% | +15.92% |
Max Drawdown (5Y)Largest decline over 5 years | -44.90% | -63.10% | +18.20% |
Max Drawdown (10Y)Largest decline over 10 years | -56.30% | -63.10% | +6.80% |
Current DrawdownCurrent decline from peak | -39.85% | -48.52% | +8.67% |
Average DrawdownAverage peak-to-trough decline | -14.82% | -31.09% | +16.27% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 17.33% | 14.86% | +2.47% |
Volatility
UHS vs. GMAB - Volatility Comparison
The current volatility for Universal Health Services, Inc. (UHS) is 7.25%, while Genmab A/S (GMAB) has a volatility of 12.15%. This indicates that UHS experiences smaller price fluctuations and is considered to be less risky than GMAB based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| UHS | GMAB | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 7.25% | 12.15% | -4.90% |
Volatility (6M)Calculated over the trailing 6-month period | 25.18% | 25.57% | -0.39% |
Volatility (1Y)Calculated over the trailing 1-year period | 31.46% | 34.45% | -2.99% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 31.82% | 33.47% | -1.65% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 34.37% | 35.19% | -0.82% |
Dividends
UHS vs. GMAB - Dividend Comparison
UHS's dividend yield for the trailing twelve months is around 0.55%, while GMAB has not paid dividends to shareholders.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
GMAB Genmab A/S | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
UHS Universal Health Services, Inc. | 0.55% | 0.37% | 0.45% | 0.52% | 0.57% | 0.62% | 0.15% | 0.42% | 0.34% | 0.35% | 0.38% | 0.33% |
Financials
UHS vs. GMAB - Financials Comparison
This section allows you to compare key financial metrics between Universal Health Services, Inc. and Genmab A/S. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
UHS vs. GMAB - Profitability Comparison
UHS - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Universal Health Services, Inc. reported a gross profit of 0.00 and revenue of 4.50B. Therefore, the gross margin over that period was 0.0%.
GMAB - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Genmab A/S reported a gross profit of 834.08M and revenue of 899.32M. Therefore, the gross margin over that period was 92.8%.
UHS - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Universal Health Services, Inc. reported an operating income of 502.86M and revenue of 4.50B, resulting in an operating margin of 11.2%.
GMAB - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Genmab A/S reported an operating income of 225.83M and revenue of 899.32M, resulting in an operating margin of 25.1%.
UHS - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Universal Health Services, Inc. reported a net income of 348.68M and revenue of 4.50B, resulting in a net margin of 7.8%.
GMAB - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Genmab A/S reported a net income of 53.20M and revenue of 899.32M, resulting in a net margin of 5.9%.
Frequently Asked Questions
UHS and GMAB have a correlation of 0.14, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
GMAB has higher volatility (12.15%) compared to UHS (7.25%). In terms of maximum drawdown, UHS dropped -60.27% vs GMAB's -84.20%.
GMAB currently has the higher Sharpe Ratio (0.25 vs -0.49), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for UHS and GMAB
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer